51 results
8-K
EX-99.2
PASG
Passage Bio Inc
14 May 24
Passage Bio Reports First Quarter 2024 Financial Results and Provides Recent Business Highlights
7:01am
. Crowell et al. Neuroepi. 2021; 55:361-368
30 Demonstrated Leadership LEADERSHIP TEAM Deep experience in rare disease, CNS disorders and genetic medicines
8-K
EX-99.1
PASG
Passage Bio Inc
4 Mar 24
Passage Bio Reports Fourth Quarter and Full-year 2023 Financial Results and Provides Recent Business Highlights
7:02am
served as the company’s Senior Vice President, Finance and Interim CFO and brings 25 years of pharmaceutical and biotech strategic financial leadership
8-K
EX-99.2
t52qw6fphnmsel de7hn
4 Mar 24
Passage Bio Reports Fourth Quarter and Full-year 2023 Financial Results and Provides Recent Business Highlights
7:02am
8-K
nvw tvxtuc8k6
4 Mar 24
Passage Bio Reports Fourth Quarter and Full-year 2023 Financial Results and Provides Recent Business Highlights
7:02am
8-K
EX-99.1
f99hn8gc
5 Jan 24
Regulation FD Disclosure
4:05pm
8-K
EX-99.2
elf t9qwueulk
13 Nov 23
Passage Bio Reports Third Quarter 2023 Financial Results and Provides Recent Business Highlights
7:00am
8-K
riifxmc33
20 Jul 23
Departure of Directors or Certain Officers
7:00am
8-K
EX-99.2
ka3x8pw63 j9
11 May 23
Passage Bio Reports First Quarter 2023 Financial Results and Provides Recent Business Highlights
7:09am
PRE 14A
gpdmqbc 915sw9c1u
3 Apr 23
Preliminary proxy
4:05pm
8-K
q3ry7edm1r0wtz ht4t
6 Jul 22
Departure of Directors or Certain Officers
7:00am